Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions

Smoldering multiple myeloma (SMM) is an asymptomatic plasma cell proliferative disorder associated with risk of progression to symptomatic multiple myeloma (MM) or amyloidosis. In comparison to monoclonal gammopathy of undetermined significance (MGUS), SMM has a much higher risk of progression to MM...

Descripción completa

Detalles Bibliográficos
Autores principales: Blum, Agnieszka, Bazou, Despina, O’Gorman, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467346/
https://www.ncbi.nlm.nih.gov/pubmed/31360091
http://dx.doi.org/10.2147/BLCTT.S136447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467346/
https://www.ncbi.nlm.nih.gov/pubmed/31360091
http://dx.doi.org/10.2147/BLCTT.S136447

Ejemplares similares